Health Sciences Group, Inc.
HESG · OTC
12/31/2012 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.02 | -0.36 | -0.50 |
| FCF Yield | 11,221.66% | -42.80% | -10.69% | -8.15% |
| EV / EBITDA | -7.13 | -1.99 | -3.25 | -6.87 |
| Quality | ||||
| ROIC | -5.95% | 1,389.92% | 672.13% | -77.54% |
| Gross Margin | 7.04% | 38.10% | 69.44% | 18.61% |
| Cash Conversion Ratio | -0.77 | 0.65 | 0.10 | 0.15 |
| Growth | ||||
| Revenue 3-Year CAGR | 74.72% | -77.62% | -77.02% | 150.38% |
| Free Cash Flow Growth | 0.00% | -287.85% | 14.73% | -101.48% |
| Safety | ||||
| Net Debt / EBITDA | -7.12 | -0.06 | -0.24 | -0.32 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 6.14 | 0.41 | 0.80 | 30.66 |
| Cash Conversion Cycle | 92.10 | -1,703.53 | -7,141.99 | -23.80 |